The study, titled Securing access, improving lives. Strengthening patients’ access to off-patent medicines in Europe, is highlighting calls for reforms to national pricing and procurement systems to secure patient access to medicines.

Key Findings

• Between 2020 and 2024, the average price of the top 10 off-patent antibiotics fell by 10.4%, while production costs and inflation surged.
• Industrial producer costs increased by 31.6%, labor costs by 25.7%, and energy prices by +88% (gas) and +62% (electricity).
• Amoxicillin prices dropped 18.9% despite being among the most affected by shortages.
• 240 antibiotic medicines were withdrawn from the market and 385 shortages reported across 16 European countries (Shortage reports were collected from each country’s health authorities between 23rd June 2025 and 7th July 2025 and they represent shortages for a specific day). Source: Securing access, improving lives. Strengthening patients’ access to off-patent medicines in Europe – independent study conducted by New Angle, sponsored by Viatris (2025).